Each material 8-K filed by an S&P 1500 company, read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (1506 companies, A–Z).
On November 5, 2026, Lam Research's board approved a $25 billion share repurchase authorization and a quarterly dividend of $0.33 per share. The authorization supplements remaining balances from the prior program and has no termination date. At the November 3, 2026 annual meeting, stockholders re-elected all 10 director nominees, approved executive pay on an advisory basis, and ratified KPMG LLP, but did not approve a stockholder proposal to call special shareholder meetings.
Board authorized up to $25 billion in share repurchases; the program may be suspended or discontinued at any time and does not obligate the company to buy any stock.
Quarterly dividend of $0.33 per share, payable January 6, 2027, to holders of record on December 2, 2026.
Advisory say-on-pay proposal passed with 93.12% of votes cast in favor.
Stockholder proposal on the right to call special shareholder meetings was not approved: 42.22% for, 556,221,352 against.
Alnylam's board authorized a program to repurchase up to $1.0 billion of its common stock on November 2, 2026. The company also said Executive Vice President and Chief Commercialization Officer Tolga Tanguler will leave in December 2026, with a separation agreement still to be signed.
Board authorized a repurchase program of up to $1.0 billion of common stock on November 2, 2026.
The company anticipates repurchasing about $500 million by the end of 2026 and the balance during 2027.
The program has no expiration date and does not obligate the company to buy any particular amount; it may be modified, suspended or discontinued at any time.
Tolga Tanguler, Executive Vice President and Chief Commercialization Officer, will depart in December 2026; the terms of his departure are yet to be set in a written agreement.
PTC Therapeutics' Board of Directors authorized a share repurchase program allowing the company to buy back up to $500 million of its common stock, subject to market conditions. The filing does not give a timing or schedule for purchases, and the company says repurchases will be made at management's discretion and reported in its Form 10-Q and Form 10-K filings.
Authorization: up to $500 million of outstanding common stock, announced November 3, 2026
Repurchases may be made from time to time at management's discretion, subject to market conditions
Methods include open-market transactions with pre-set trading plans, privately negotiated deals, and accelerated share repurchases
CEO Matthew B. Klein said the program leaves financial flexibility to support existing programs and pursue potential business development transactions
Mueller Water Products' board raised its quarterly dividend 14.3%, to $0.080 per share from $0.070, and authorized an additional $300 million for stock repurchases. About $334.5 million is now available under the expanded program. The moves return more capital to shareholders, and the company said it gives it flexibility to repurchase shares when it believes they are undervalued.
Quarterly dividend of $0.080 per share, up 14.3% from $0.070, payable November 19, 2026, to holders of record on November 9, 2026
Board added $300 million to the existing repurchase program, bringing available authorization to about $334.5 million
Company repurchased $30.5 million of common stock in fiscal 2026, including $15.0 million in the quarter ended September 30, 2026
Matador Resources amended its dividend policy and declared a quarterly cash dividend of $0.4375 per share, up from $0.375 under the prior policy. The company says the increase is its eighth in five years, and future dividends remain at the discretion of the Board, depending on results, cash flows and other factors.
New policy sets $0.4375 per share per quarter, or $1.75 per share per year, beginning in the fourth quarter of 2026
Increase is 17% over the prior policy of $0.375 per share per quarter, or $1.50 per year
Dividend is payable December 4, 2026, to shareholders of record as of November 10, 2026
CEO Joseph Wm. Foran called it the eighth increase in five years and tied it to free cash flow and debt repayment
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by S&P 500, MidCap 400 and SmallCap 600 companies that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
The SEC filing feed is checked every hour on weekdays between 6 am and 10 pm Eastern; briefs follow within that hour or, when many filings arrive at once, later the same day.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.